The Genetics Behind Anxiety Disorders

News   Aug 12, 2016

 
The Genetics Behind Anxiety Disorders
 
 
 

RELATED ARTICLES

CRISPR Study Reveals Errors in Earlier Cancer Research

News

MELK, a protein previously thought to be implicated in cancer, has been shown to be unrelated to the disease.

READ MORE

Microscopic Movie Shows How DNA Gets in Shape

News

DNA is folded into loops by a protein called condensin, and the process has been filmed for the first time.

READ MORE

3D Metabolic Map is Computational First

News

The computer model integrates over 4,000 metabolites and 13,000 proteins.

READ MORE

 

Comments | 1 ADD COMMENT

Ana Aitawa | Oct 03, 2017

The global anxiety disorders and depression treatment market is estimated to reach US$ 18 Billion in 2021, growing at a CAGR of 0.9% from 2017 to 2021. Visit Anxiety Disorders and Depression Treatment Market by Drug Class (Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake, Atypical Antipsychotics, Tricyclic Antidepressants, Tetracyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Anticonvulsants) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/anxiety-disorders-depression-treatment-market/


Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE